Related Experiment Video
Updated: May 5, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomavirus vaccine national catch-up program - insights into under-notification
Ingrid Laemmle-Ruff1, Bianca Barbaro, Julia Brotherton
1MBBS (Hons), MPH, Public Health Registrar, Office of the Chief Health Officer, Department of Health, Melbourne, Victoria; Paediatric Resident, Monash Children's Hospital, Melbourne, Victoria.
Background:
We analysed human papillomavirus (HPV) vaccination coverage from the 2007-2009 catch-up program for women aged 18-26 years by Division of General Practice (DGP), alongside a survey about under-notification.
Methods:
Coverage rates were calculated from the National HPV Vaccination Program Register. An online survey of immunisation coordinators in DGP assessed under-notification.
Results:
HPV vaccine coverage by DGPs varied greatly: dose 1, 22-70%; dose 2, 13-60%; dose 3, 7-49%. Most coordinators (38/52, 66%) believed that more than 80% of practices notified the register. Perceived notification barriers included being busy, not knowing how to notify, not obtaining consent, insufficient remuneration and delay in register establishment.
Discussion:
DGP coverage varied widely. Process barriers (time and resource limitations) probably contributed to under-notification, with informational barriers (unaware how to notify) and motivational barriers (not worth the effort) secondary to this. Differences in reported coverage between DGPs and states reflect both differences in notification rates and underlying HPV vaccine coverage.
More Related Videos
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Related Concept Videos
Vaccinations
Principles of Disease Surveillance
Infectious Diseases and Their Occurrence
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines